Hypofractionated radiotherapy combined with bevacizumab plus low-dose ifosfamide, carboplatin, and etoposide as second-line chemoradiotherapy for progressing spinal diffuse midline glioma, H3K27-altered: illustrative case.
Shintaro Nakayasu; Masahiro Tanji; Megumi Uto; Yasuhide Takeuchi; Yasuhide Makino; Etsuko Yamamoto Hattori; Yukinori Terada; Noritaka Sano; Yohei Mineharu; Takashi Mizowaki; Yoshiki Arakawa
Journal of neurosurgery. Case lessons, 2024年08月12日